Pulmonary toxicity |
2–11 |
[20, 21, 24, 33] |
Hematopoietic adverse effects |
|
|
Anemia |
13–58 |
[6, 36, 44–47, 50, 56, 57, 70, 72, 135, 147] |
Leukopenia |
5–39 |
[6, 45, 46, 56, 66, 117, 121, 147] |
Thrombocytopenia |
4–45 |
[6, 45–47, 56, 66, 70, 117, 118, 121, 122, 147] |
Metabolic disorders |
|
|
Hyperlipidemia |
8–87 |
[6, 45–47, 57, 66, 70–72, 115, 117, 118, 121, 135, 147] |
Posttransplantation diabetes |
3–33 |
[56, 70, 72, 78, 80, 115, 121, 138, 147] |
Hypophosphatemia |
15–20 |
[45, 46, 57] |
Lymphedema |
<5 |
[99–102] |
Cardiovascular disease |
1–6 |
[80, 100, 117, 122, 124, 128] |
Hypertension |
8–58 |
[46, 57, 70, 72, 115, 117, 121, 122, 135] |
Cutaneous adverse effects |
|
|
Acne, folliculitis |
9–25 |
[6, 57, 70, 116–118, 135, 147] |
Stomatitis and mucous membrane disorders |
9–64 |
[6, 118, 138, 147] |
Edema |
2–70 |
[6, 56, 57, 70, 121, 122, 135, 147] |
Nail and hair pathologies |
74 |
[116] |
Gonadal complications |
<5 |
[123–126] |
Surgical wound complication |
2–20 |
[56, 70, 72, 133–136] |
Infections |
2–60 |
[6, 72, 117, 122, 136] |
Gastrointestinal complication |
2–51 |
[6, 46, 47, 56, 57, 70, 72, 117, 118, 121, 135, 147] |